IRON DEFICIENCY AND IRON-DEFICIENCY ANAEMIA IN PREGNANT WOMEN CORRECTED BY ORAL BOVINE LACTOFERRIN ADMINISTRATION

Iron deficiency and iron - deficiency anaemia represent factors which increase maternal, foetal and neonatal mortality and morbidity. In pregnancy, the failure of oral iron-based therapy in restoring the biological parameters made it necessary to pursue other solutions. Due to its iron-binding properties, bovine lactoferrin has been used in preventing and treating iron - deficiency anaemia in pregnancy. In our study, 406 patients of different ages, parities and gestational ages received oral therapy with bovine lactoferrin, 100 mg twice a day. After 90 days, more than 90% of patients that completed the study had a positive response. These considerations, as well as positive neonatal results, support the claim that the use of bovine lactoferrin re-balances iron levels in pregnant women with iron deficiency and iron-deficiency anaemia.